12:00 AM
 | 
Apr 08, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Mitsubishi Tanabe Pharma sales and marketing update

Mitsubishi's Mitsubishi Pharma Deutschland GmbH subsidiary launched BindRen colestilan in Germany and Austria to treat hyperphosphatemia in adult patients with stage 5 chronic kidney disease (CKD) receiving hemodialysis or peritoneal dialysis. Mitsubishi said...

Read the full 154 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >